We demonstrate that the substitution of one nucleotide for expressing the APOL1 G1 or deletion of six nucleotides for expressing the APOL1 G2 led to a significant alteration in cell metabolism and tumorigenic potential in RCC cancer cells, as did deleting the endogenous gene. This evidence concerns the gene APOL1 and renal cell carcinoma.